Saturn V Capital Management LLC Ocular Therapeutix, Inc Transaction History
Saturn V Capital Management LLC
- $247 Billion
- Q2 2025
A detailed history of Saturn V Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 728,576 shares of OCUL stock, worth $9.09 Million. This represents 2.74% of its overall portfolio holdings.
Number of Shares
728,576
Previous 598,191
21.8%
Holding current value
$9.09 Million
Previous $4.38 Billion
54.2%
% of portfolio
2.74%
Previous 2.21%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$178 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$173 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$159 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$105 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $961M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...